Eflornithine - CAS 70052-12-9
Catalog number: 70052-12-9
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
COA:
Inquire
Targets:
Others
Description:
Eflornithine is a difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells.
Publictions citing BOC Sciences Products
  • >> More
Synonyms:
CPP-1X, 2-difluoromethylornithine; alpha-difluoromethylornithine; difluromethylornithine;
MSDS:
Inquire
Current Developer:
Cancer Prevention Pharmaceuticals.
1.Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri H1, Benavides A1, Haber M1, Gilmour SK1, Norris MD1, Hogarty MD1. Transl Pediatr. 2015 Jul;4(3):226-38. doi: 10.3978/j.issn.2224-4336.2015.04.06.
Neuroblastoma is a childhood tumor in which MYC oncogenes are commonly activated to drive tumor progression. Survival for children with high-risk neuroblastoma remains poor despite treatment that incorporates high-dose chemotherapy, stem cell support, surgery, radiation therapy and immunotherapy. More effective and less toxic treatments are sought and one approach under clinical development involves re-purposing the anti-protozoan drug difluoromethylornithine (DFMO; Eflornithine) as a neuroblastoma therapeutic. DFMO is an irreversible inhibitor of ornithine decarboxylase (Odc), a MYC target gene, bona fide oncogene, and the rate-limiting enzyme in polyamine synthesis. DFMO is approved for the treatment of Trypanosoma brucei gambiense encephalitis ("African sleeping sickness") since polyamines are essential for the proliferation of these protozoa. However, polyamines are also critical for mammalian cell proliferation and the finding that MYC coordinately regulates all aspects of polyamine metabolism suggests polyamines may be required to support cancer promotion by MYC.
2.Input estimation for drug discovery using optimal control and Markov chain Monte Carlo approaches.
Trägårdh M1,2, Chappell MJ3, Ahnmark A4, Lindén D4, Evans ND3, Gennemark P5. J Pharmacokinet Pharmacodyn. 2016 Apr;43(2):207-21. doi: 10.1007/s10928-016-9467-z. Epub 2016 Mar 1.
Input estimation is employed in cases where it is desirable to recover the form of an input function which cannot be directly observed and for which there is no model for the generating process. In pharmacokinetic and pharmacodynamic modelling, input estimation in linear systems (deconvolution) is well established, while the nonlinear case is largely unexplored. In this paper, a rigorous definition of the input-estimation problem is given, and the choices involved in terms of modelling assumptions and estimation algorithms are discussed. In particular, the paper covers Maximum a Posteriori estimates using techniques from optimal control theory, and full Bayesian estimation using Markov Chain Monte Carlo (MCMC) approaches. These techniques are implemented using the optimisation software CasADi, and applied to two example problems: one where the oral absorption rate and bioavailability of the drug eflornithine are estimated using pharmacokinetic data from rats, and one where energy intake is estimated from body-mass measurements of mice exposed to monoclonal antibodies targeting the fibroblast growth factor receptor (FGFR) 1c.
3.Quilamine HQ1-44, an iron chelator vectorized toward tumor cells by the polyamine transport system, inhibits HCT116 tumor growth without adverse effect.
Renaud S1, Corcé V2, Cannie I3, Ropert M4, Lepage S5, Loréal O3, Deniaud D6, Gaboriau F7. Biochem Pharmacol. 2015 Aug 1;96(3):179-89. doi: 10.1016/j.bcp.2015.06.001. Epub 2015 Jun 10.
Tumor cell growth requires large iron quantities and the deprivation of this metal induced by synthetic metal chelators is therefore an attractive method for limiting the cancer cell proliferation. The antiproliferative effect of the Quilamine HQ1-44, a new iron chelator vectorized toward tumor cells by a polyamine chain, is related to its high selectivity for the Polyamine Transport System (PTS), allowing its preferential uptake by tumoral cells. The difference in PTS activation between healthy cells and tumor cells enables tumor cells to be targeted, whereas the strong dependence of these cells on iron ensures a secondary targeting. Here, we demonstrated in vitro that HQ1-44 inhibits DNA synthesis and cell proliferation of HCT116 cells by modulating the intracellular metabolism of both iron and polyamines. Moreover, in vivo, in xenografted athymic nude mice, we found that HQ1-44 was as effective as cis-platin in reducing HCT116 tumor growth, without its side effects.
4.Suppression of ornithine decarboxylase promotes osteogenic differentiation of human bone marrow-derived mesenchymal stem cells.
Tsai YH1, Lin KL1, Huang YP2, Hsu YC3, Chen CH4, Chen Y5, Sie MH1, Wang GJ6, Lee MJ7. FEBS Lett. 2015 Jul 22;589(16):2058-65. doi: 10.1016/j.febslet.2015.06.023. Epub 2015 Jun 30.
Ornithine decarboxylase (ODC) is the rate-limiting enzyme for polyamine biosynthesis. Suppression of ODC by its irreversible inhibitor, α-difluoromethylornithine (DFMO), or by RNA interference through siRNA, enhanced osteogenic gene expression and alkaline phosphatase activity, and accelerated matrix mineralization of human bone marrow-derived mesenchymal stem cells (hBMSCs). Besides, adipogenic gene expression and lipid accumulation was attenuated, indicating that the enhanced osteogenesis was accompanied by down-regulation of adipogenesis when ODC was suppressed. A decrease in the intracellular polyamine content of hBMSCs during osteogenic induction was observed, suggesting that the level of endogenous polyamines is regulated during differentiation of hBMSCs. This study elucidates the role of polyamine metabolism in the lineage commitment of stem cells and provides a potential new indication for DFMO as bone-stimulating drug.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 104723-60-6 6-O-α-D-Maltosyl-β-cyclodextrin

6-O-α-D-Maltosyl-β-cyclodextrin
(CAS: 104723-60-6)

6-O-α-D-Maltosyl-β-cyclodextrin is a cellular cholesterol modifier which can form soluble inclusion complex with cholesterol and is much less cytotoxic to human...

CAS 67920-52-9 Sodium Danshensu

Sodium Danshensu
(CAS: 67920-52-9)

Sodium Danshensu is a mono sodium of danshensu, which is a natural phenolic acid of caffeic acid derivatives isolated from Salvia miltiorrhiza.

CAS 78214-33-2 Ginsenoside Rh2

Ginsenoside Rh2
(CAS: 78214-33-2)

Ginsenoside Rh2 is a bioactive metabolite of the ginsenoside component of Panax ginseng. It is a potent anti-inflammatory and anticancer drug and exhibits antib...

CAS 72962-43-7 Brassinolide

Brassinolide
(CAS: 72962-43-7)

Brassinolide is a plant sterol first isolated from pollen of rape (Brassica napus L.). It could promote stem elongation and cell division.

CAS 383124-82-1 YE 120

YE 120
(CAS: 383124-82-1)

YE 120 is a GPR35 agonist (EC50 = 32 nM in DMR assays), and also displays partial agonist activity in a β-arrestin translocation assay (EC50 = 10.2 μM).

CAS 141195-77-9 Cefovecin sodium

Cefovecin sodium
(CAS: 141195-77-9)

Cefovecin Sodium is an antibiotic of the cephalosporin class. It is used for the treatment of skin infections caused by Pasturella multocida in cats, and Staphy...

QL9

QL9 (QLSPFPFDL), derived from the enzyme 2-oxoglutarate dehydrogenase, is a high-affinity alloantigen for the 2C T cell receptor (TCR).

CAS 51298-62-5 L-NAME HCl

L-NAME HCl
(CAS: 51298-62-5)

L-NAME is a nonselective inhibitor of nitric oxide synthetases (NOS) for nNOS (bovine), eNOS (human), and iNOS (murine), with Ki of 15 nM, 39 nM and 4.4 μM, res...

CAS 75614-09-4 GYKI-13380

GYKI-13380
(CAS: 75614-09-4)

GYKI-13380is a bio-active compound. But no detailed information has been published ye

CAS 83-73-8 5,7-Diiodo-8-Quinolinol

5,7-Diiodo-8-Quinolinol
(CAS: 83-73-8)

5,7-Diiodo-8-Quinolinol is a topical therapeutic agent with satisfactory antibacterial properties. It is poorly absorbed from the gastrointestinal tract and is ...

Berubicin Hydrochloride
(CAS: 293736-67-1)

Berubicin hydrochloride is hydrochloride salt of the anthracycline derivative berubicin as a topoisomerase II inhibitor with activity in ependymoma.

Gyki 13324
(CAS: 76123-41-6)

GYKI-13324 is bifunctional nitrosoureido derivative and alkylating agent. It can produce long-term or total regression of adenomatous, but only marginal growth ...

CAS 125-03-1 Hydrocortamate hydrochloride

Hydrocortamate hydrochloride
(CAS: 125-03-1)

This active molecular is a synthetic glucocorticoid with immunosuppressive and anti-inflammatory properties. Hydrocortamate hydrochloride is applicated for the ...

CAS 406-76-8 DL-Carnitine

DL-Carnitine
(CAS: 406-76-8)

Carnitine regulates fatty acid transport in mitochondria, elevates serum carnitine fractions.

CAS 472-26-4 Telocinobufagin

Telocinobufagin
(CAS: 472-26-4)

Telocinobufagin is one of anti-hepatoma constituent in Venenum Bufonis.

CAS 5451-09-2 5-Aminolevulinic acid hydrochloride

5-Aminolevulinic acid hydrochloride
(CAS: 5451-09-2)

5-Aminolevulinic acid HCl is an intermediate in heme biosynthesis in the body and the universal precursor of tetrapyrroles. 5-Aminolevulinic acid is used as a p...

CAS 265980-25-4 SCH 202676 hydrobromide

SCH 202676 hydrobromide
(CAS: 265980-25-4)

SCH 202676 hydrobromide is a reversible inhibitor of agonist and antagonist binding to G-protein-coupled receptors. It inhibits a variety of GPCRs including ade...

CAS 56296-18-5 DREADD agonist 21

DREADD agonist 21
(CAS: 56296-18-5)

DREADD agonist 21 has been found to be an agonist of hM3Dq with high selectivity.

CAS 922732-52-3 SSM 3 trifluoroacetate

SSM 3 trifluoroacetate
(CAS: 922732-52-3)

SSM 3 trifluoroacetate is a potent furin inhibitor (EC50 = 54 nM) which blocks furin-dependent cell surface processing of anthrax protective antigen-83 in vitro...

CAS 110623-72-8 Epimedin A

Epimedin A
(CAS: 110623-72-8)

Epimedin A, a flavonoids natural product extracted from Herbal Epimedium, could increase cardiovascular blood flow, promote hematopoietic function and has poten...

Chemical Structure

CAS 70052-12-9 Eflornithine

Quick Inquiry

Verification code

Featured Items